# Interlink Electronics Inc: financial statements, quarterly

LINK · Nasdaq · CIK 828146 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/link.md) · [Financials](/companies/link/financials.md) · [Filings](/companies/link/filings.md) · [Insiders](/companies/link/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/link/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,075](/filings/0001410578-24-001798.md) | [3,538 d](/filings/0001410578-25-000511.md) | [3,124](/filings/0001410578-25-001225.md) | [2,898](/filings/0001410578-25-001738.md) | [2,671](/filings/0001104659-25-110356.md) | [2,986 d](/filings/0001104659-26-035244.md) | [2,664](/filings/0001104659-26-061139.md) | [3,414](/filings/0001104659-26-096041.md) | [2,959](/filings/0001104659-25-110356.md) | [2,853 d](/filings/0001104659-26-035244.md) | [3,074](/filings/0001104659-26-061139.md) | [3,770](/filings/0001104659-26-096041.md) |
| Cost of revenue | $k | [1,616](/filings/0001410578-24-001798.md) | [2,086 d](/filings/0001410578-25-000511.md) | [1,871](/filings/0001410578-25-001225.md) | [1,593](/filings/0001410578-25-001738.md) | [1,566](/filings/0001104659-25-110356.md) | [1,803 d](/filings/0001104659-26-035244.md) | [1,715](/filings/0001104659-26-061139.md) | [1,876](/filings/0001104659-26-096041.md) | [1,721](/filings/0001104659-25-110356.md) | [1,948 d](/filings/0001104659-26-035244.md) | [1,738](/filings/0001104659-26-061139.md) | [2,098](/filings/0001104659-26-096041.md) |
| Gross profit | $k | [1,459](/filings/0001410578-24-001798.md) | [1,452 d](/filings/0001410578-25-000511.md) | [1,253](/filings/0001410578-25-001225.md) | [1,305](/filings/0001410578-25-001738.md) | [1,105](/filings/0001104659-25-110356.md) | [1,183 d](/filings/0001104659-26-035244.md) | [949](/filings/0001104659-26-061139.md) | [1,538](/filings/0001104659-26-096041.md) | [1,238](/filings/0001104659-25-110356.md) | [905 d](/filings/0001104659-26-035244.md) | [1,336](/filings/0001104659-26-061139.md) | [1,672](/filings/0001104659-26-096041.md) |
| Research and development | $k | [588](/filings/0001410578-24-001798.md) | [561 d](/filings/0001410578-25-000511.md) | [576](/filings/0001410578-25-001225.md) | [510](/filings/0001410578-25-001738.md) | [486](/filings/0001104659-25-110356.md) | [480 d](/filings/0001104659-26-035244.md) | [434](/filings/0001104659-26-061139.md) | [363](/filings/0001104659-26-096041.md) | [354](/filings/0001104659-25-110356.md) | [353 d](/filings/0001104659-26-035244.md) | [303](/filings/0001104659-26-061139.md) | [262](/filings/0001104659-26-096041.md) |
| Selling, general and administrative | $k | [963](/filings/0001410578-24-001798.md) | [1,471 d](/filings/0001410578-25-000511.md) | [1,428](/filings/0001410578-25-001225.md) | [1,108](/filings/0001410578-25-001738.md) | [1,095](/filings/0001104659-25-110356.md) | [1,213 d](/filings/0001104659-26-035244.md) | [1,364](/filings/0001104659-26-061139.md) | [1,109](/filings/0001104659-26-096041.md) | [1,197](/filings/0001104659-25-110356.md) | [1,285 d](/filings/0001104659-26-035244.md) | [1,483](/filings/0001104659-26-061139.md) | [1,164](/filings/0001104659-26-096041.md) |
| Operating income | $k | [(92.0)](/filings/0001410578-24-001798.md) | [(580) d](/filings/0001410578-25-000511.md) | [(751)](/filings/0001410578-25-001225.md) | [(313)](/filings/0001410578-25-001738.md) | [(476)](/filings/0001104659-25-110356.md) | [(510) d](/filings/0001104659-26-035244.md) | [(849)](/filings/0001104659-26-061139.md) | [66.0](/filings/0001104659-26-096041.md) | [(313)](/filings/0001104659-25-110356.md) | [(733) d](/filings/0001104659-26-035244.md) | [(450)](/filings/0001104659-26-061139.md) | [246](/filings/0001104659-26-096041.md) |
| Income tax | $k | [59.0](/filings/0001410578-24-001798.md) | [(122) d](/filings/0001410578-25-000511.md) | [22.0](/filings/0001410578-25-001225.md) | [10.0](/filings/0001410578-25-001738.md) | [28.0](/filings/0001104659-25-110356.md) | [(33.0) d](/filings/0001104659-26-035244.md) | [(39.0)](/filings/0001104659-26-061139.md) | [(9.0)](/filings/0001104659-26-096041.md) | [26.0](/filings/0001104659-25-110356.md) | [(169) d](/filings/0001104659-26-035244.md) | [(52.0)](/filings/0001104659-26-061139.md) | [(17.0)](/filings/0001104659-26-096041.md) |
| Net income | $k | [(125)](/filings/0001410578-24-001798.md) | [(448) d](/filings/0001410578-25-000511.md) | [(741)](/filings/0001410578-25-001225.md) | [(307)](/filings/0001410578-25-001738.md) | [(523)](/filings/0001104659-25-110356.md) | [(413) d](/filings/0001104659-26-035244.md) | [(805)](/filings/0001104659-26-061139.md) | [100](/filings/0001104659-26-096041.md) | [(336)](/filings/0001104659-25-110356.md) | [(574) d](/filings/0001104659-26-035244.md) | [(338)](/filings/0001104659-26-061139.md) | [248](/filings/0001104659-26-096041.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001410578-24-001798.md) | not reported | [(0.09)](/filings/0001410578-25-001225.md) | [(0.04)](/filings/0001410578-25-001738.md) | [(0.04)](/filings/0001104659-25-110356.md) | not reported | [(0.06)](/filings/0001104659-26-061139.md) | not reported | [(0.03)](/filings/0001104659-25-110356.md) | not reported | [(0.02)](/filings/0001104659-26-061139.md) | [0.02](/filings/0001104659-26-096041.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001410578-24-001798.md) | not reported | [(0.09)](/filings/0001410578-25-001225.md) | [(0.04)](/filings/0001410578-25-001738.md) | [(0.04)](/filings/0001104659-25-110356.md) | not reported | [(0.06)](/filings/0001104659-26-061139.md) | not reported | [(0.03)](/filings/0001104659-25-110356.md) | not reported | [(0.02)](/filings/0001104659-26-061139.md) | [0.02](/filings/0001104659-26-096041.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.2](/filings/0001104659-23-116252.md) | [4.3](/filings/0001410578-25-000511.md) | [4.4](/filings/0001410578-24-000702.md) | [4.0](/filings/0001410578-24-001230.md) | [3.8](/filings/0001410578-24-001798.md) | [3.0](/filings/0001104659-26-035244.md) | [2.6](/filings/0001410578-25-001225.md) | [2.3](/filings/0001410578-25-001738.md) | [3.0](/filings/0001104659-25-110356.md) | [2.7](/filings/0001104659-26-096041.md) | [2.1](/filings/0001104659-26-061139.md) | [1.8](/filings/0001104659-26-096041.md) |
| Current assets | $m | [9.9](/filings/0001104659-23-116252.md) | [9.3](/filings/0001410578-25-000511.md) | [9.1](/filings/0001410578-24-000702.md) | [8.3](/filings/0001410578-24-001230.md) | [7.7](/filings/0001410578-24-001798.md) | [6.9](/filings/0001104659-26-035244.md) | [6.4](/filings/0001410578-25-001225.md) | [6.4](/filings/0001410578-25-001738.md) | [6.4](/filings/0001104659-25-110356.md) | [6.3](/filings/0001104659-26-096041.md) | [6.1](/filings/0001104659-26-061139.md) | [6.0](/filings/0001104659-26-096041.md) |
| Total assets | $m | [15.3](/filings/0001104659-23-116252.md) | [15.1](/filings/0001410578-25-000511.md) | [14.5](/filings/0001410578-24-000702.md) | [14.2](/filings/0001410578-24-001230.md) | [14.1](/filings/0001410578-24-001798.md) | [13.1](/filings/0001104659-26-035244.md) | [12.5](/filings/0001410578-25-001225.md) | [12.5](/filings/0001410578-25-001738.md) | [12.1](/filings/0001104659-25-110356.md) | [11.7](/filings/0001104659-26-096041.md) | [11.1](/filings/0001104659-26-061139.md) | [11.2](/filings/0001104659-26-096041.md) |
| Current liabilities | $m | [2.0](/filings/0001104659-23-116252.md) | [1.4](/filings/0001410578-25-000511.md) | [1.8](/filings/0001410578-24-000702.md) | [1.4](/filings/0001410578-24-001230.md) | [1.3](/filings/0001410578-24-001798.md) | [1.4](/filings/0001104659-26-035244.md) | [1.6](/filings/0001410578-25-001225.md) | [1.4](/filings/0001410578-25-001738.md) | [1.5](/filings/0001104659-25-110356.md) | [1.7](/filings/0001104659-26-096041.md) | [1.7](/filings/0001104659-26-061139.md) | [1.3](/filings/0001104659-26-096041.md) |
| Total liabilities | $m | [2.0](/filings/0001104659-23-116252.md) | [2.0](/filings/0001410578-25-000511.md) | [2.4](/filings/0001410578-24-000702.md) | [2.6](/filings/0001410578-24-001230.md) | [2.7](/filings/0001410578-24-001798.md) | [2.6](/filings/0001104659-26-035244.md) | [2.7](/filings/0001410578-25-001225.md) | [2.5](/filings/0001410578-25-001738.md) | [2.4](/filings/0001104659-25-110356.md) | [2.5](/filings/0001104659-26-096041.md) | [2.4](/filings/0001104659-26-061139.md) | [2.2](/filings/0001104659-26-096041.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [13.3](/filings/0001410578-24-001798.md) | [13.0](/filings/0001104659-26-035244.md) | [12.1](/filings/0001410578-25-001738.md) | [11.7](/filings/0001104659-25-110356.md) | [11.5](/filings/0001104659-25-110356.md) | [10.5](/filings/0001104659-26-096041.md) | [9.8](/filings/0001104659-26-096041.md) | [10.0](/filings/0001104659-26-096041.md) | [9.6](/filings/0001104659-25-110356.md) | [9.2](/filings/0001104659-26-096041.md) | [8.7](/filings/0001104659-26-096041.md) | [9.0](/filings/0001104659-26-096041.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [400 d](/filings/0001410578-24-001798.md) | [(271) d](/filings/0001410578-25-000511.md) | [222](/filings/0001410578-25-001225.md) | [(298) d](/filings/0001410578-25-001738.md) | [(68.0) d](/filings/0001104659-25-110356.md) | [(223) d](/filings/0001104659-26-035244.md) | [(271)](/filings/0001104659-26-061139.md) | [(138) d](/filings/0001104659-26-096041.md) | [653 d](/filings/0001104659-25-110356.md) | [(356) d](/filings/0001104659-26-035244.md) | [(543)](/filings/0001104659-26-061139.md) | [(286) d](/filings/0001104659-26-096041.md) |
| Capital expenditure | $k | [12.0 d](/filings/0001410578-24-001798.md) | [79.0 d](/filings/0001410578-25-000511.md) | [18.0](/filings/0001410578-25-001225.md) | [2.0 d](/filings/0001410578-25-001738.md) | [87.0 d](/filings/0001104659-25-110356.md) | [70.0 d](/filings/0001104659-26-035244.md) | [29.0](/filings/0001104659-26-061139.md) | [5.0 d](/filings/0001104659-26-096041.md) | [3.0 d](/filings/0001104659-25-110356.md) | [19.0 d](/filings/0001104659-26-035244.md) | not reported | not reported |
| Share repurchases | $k | [173 d](/filings/0001410578-24-001798.md) | [0.0 d](/filings/0001410578-25-000511.md) | not reported | not reported | [0.0 d](/filings/0001410578-24-001798.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.6](/filings/0001104659-23-116252.md) | [9.9](/filings/0001410578-24-000702.md) | [9.9](/filings/0001410578-24-001230.md) | [9.9](/filings/0001410578-24-001798.md) | [9.9](/filings/0001410578-25-001225.md) | [9.9](/filings/0001410578-25-001738.md) | [14.8](/filings/0001104659-25-110356.md) | [14.8](/filings/0001104659-26-061139.md) | [14.8](/filings/0001104659-26-096041.md) | [14.8](/filings/0001104659-25-110356.md) | [15.8](/filings/0001104659-26-061139.md) | [15.8](/filings/0001104659-26-096041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,753,409 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001104659-26-096041.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.